These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
213 related articles for article (PubMed ID: 25169075)
1. Manufacturing scale-up of electrospun poly(vinyl alcohol) fibers containing tenofovir for vaginal drug delivery. Krogstad EA; Woodrow KA Int J Pharm; 2014 Nov; 475(1-2):282-91. PubMed ID: 25169075 [TBL] [Abstract][Full Text] [Related]
2. Delivery of multipurpose prevention drug combinations from electrospun nanofibers using composite microarchitectures. Blakney AK; Krogstad EA; Jiang YH; Woodrow KA Int J Nanomedicine; 2014; 9():2967-78. PubMed ID: 24971008 [TBL] [Abstract][Full Text] [Related]
3. Increased Dapivirine tissue accumulation through vaginal film codelivery of dapivirine and Tenofovir. Akil A; Devlin B; Cost M; Rohan LC Mol Pharm; 2014 May; 11(5):1533-41. PubMed ID: 24693866 [TBL] [Abstract][Full Text] [Related]
4. Durable protection from vaginal simian-human immunodeficiency virus infection in macaques by tenofovir gel and its relationship to drug levels in tissue. Dobard C; Sharma S; Martin A; Pau CP; Holder A; Kuklenyik Z; Lipscomb J; Hanson DL; Smith J; Novembre FJ; García-Lerma JG; Heneine W J Virol; 2012 Jan; 86(2):718-25. PubMed ID: 22072766 [TBL] [Abstract][Full Text] [Related]
5. Quantitative evaluation of a hydrophilic matrix intravaginal ring for the sustained delivery of tenofovir. Clark JT; Johnson TJ; Clark MR; Nebeker JS; Fabian J; Tuitupou AL; Ponnapalli S; Smith EM; Friend DR; Kiser PF J Control Release; 2012 Oct; 163(2):240-8. PubMed ID: 22981701 [TBL] [Abstract][Full Text] [Related]
6. Development of a combination microbicide gel formulation containing IQP-0528 and tenofovir for the prevention of HIV infection. Ham AS; Ugaonkar SR; Shi L; Buckheit KW; Lakougna H; Nagaraja U; Gwozdz G; Goldman L; Kiser PF; Buckheit RW J Pharm Sci; 2012 Apr; 101(4):1423-35. PubMed ID: 22227864 [TBL] [Abstract][Full Text] [Related]
7. Formulation and characterization of polymeric films containing combinations of antiretrovirals (ARVs) for HIV prevention. Akil A; Agashe H; Dezzutti CS; Moncla BJ; Hillier SL; Devlin B; Shi Y; Uranker K; Rohan LC Pharm Res; 2015 Feb; 32(2):458-68. PubMed ID: 25079391 [TBL] [Abstract][Full Text] [Related]
8. Simultaneous delivery of tenofovir and acyclovir via an intravaginal ring. Moss JA; Malone AM; Smith TJ; Kennedy S; Kopin E; Nguyen C; Gilman J; Butkyavichene I; Vincent KL; Motamedi M; Friend DR; Clark MR; Baum MM Antimicrob Agents Chemother; 2012 Feb; 56(2):875-82. PubMed ID: 22123689 [TBL] [Abstract][Full Text] [Related]
9. Synergistic activity of tenofovir and nevirapine combinations released from polycaprolactone matrices for potential enhanced prevention of HIV infection through the vaginal route. Dang NT; Sivakumaran H; Harrich D; Shaw PN; Davis-Poynter N; Coombes AG Eur J Pharm Biopharm; 2014 Oct; 88(2):406-14. PubMed ID: 24887313 [TBL] [Abstract][Full Text] [Related]
10. Safety and pharmacokinetics of intravaginal rings delivering tenofovir in pig-tailed macaques. Moss JA; Malone AM; Smith TJ; Butkyavichene I; Cortez C; Gilman J; Kennedy S; Kopin E; Nguyen C; Sinha P; Hendry RM; Guenthner P; Holder A; Martin A; McNicholl J; Mitchell J; Pau CP; Srinivasan P; Smith JM; Baum MM Antimicrob Agents Chemother; 2012 Nov; 56(11):5952-60. PubMed ID: 22964245 [TBL] [Abstract][Full Text] [Related]
11. Electrospun fibers for vaginal anti-HIV drug delivery. Blakney AK; Ball C; Krogstad EA; Woodrow KA Antiviral Res; 2013 Dec; 100 Suppl():S9-16. PubMed ID: 24188701 [TBL] [Abstract][Full Text] [Related]
12. Pharmacokinetics and preliminary safety study of pod-intravaginal rings delivering antiretroviral combinations for HIV prophylaxis in a macaque model. Moss JA; Srinivasan P; Smith TJ; Butkyavichene I; Lopez G; Brooks AA; Martin A; Dinh CT; Smith JM; Baum MM Antimicrob Agents Chemother; 2014 Sep; 58(9):5125-35. PubMed ID: 24936594 [TBL] [Abstract][Full Text] [Related]
13. Vaginal deployment and tenofovir delivery by microbicide gels. Gao Y; Yuan A; Chuchuen O; Ham A; Yang KH; Katz DF Drug Deliv Transl Res; 2015 Jun; 5(3):279-94. PubMed ID: 25874971 [TBL] [Abstract][Full Text] [Related]
14. A 90-day tenofovir reservoir intravaginal ring for mucosal HIV prophylaxis. Johnson TJ; Clark MR; Albright TH; Nebeker JS; Tuitupou AL; Clark JT; Fabian J; McCabe RT; Chandra N; Doncel GF; Friend DR; Kiser PF Antimicrob Agents Chemother; 2012 Dec; 56(12):6272-83. PubMed ID: 23006751 [TBL] [Abstract][Full Text] [Related]
15. pH-responsive nanoparticles releasing tenofovir intended for the prevention of HIV transmission. Zhang T; Sturgis TF; Youan BB Eur J Pharm Biopharm; 2011 Nov; 79(3):526-36. PubMed ID: 21736940 [TBL] [Abstract][Full Text] [Related]